Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer- A Cost-Effectiveness Analysis Of The Aurelia Trial
Abstract
Authors
EM Schaffer TM Coles WZ Wysham DR Roque KH Kim SB Wheeler